Arranta Bio LLC is a contract development and manufacturing organization specializing in the development and production of live biopharmaceutical products, particularly those targeting human microbiome-related diseases. Founded in 2019 and headquartered in Watertown, Massachusetts, the company offers a comprehensive range of services, including media formulation, cell banking, fermentation, lyophilization, and analytical services, all conducted under current Good Manufacturing Practices (cGMP). Arranta Bio operates a process development and cGMP manufacturing facility in Gainesville, Florida, where it focuses on bacterial fermentation, isolation, drying, and encapsulation processes for live biotherapeutic products. The company aims to support innovators in the healthcare sector in bringing effective treatments to market through its advanced manufacturing capabilities.
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.
Captozyme
Acquisition in 2019
Captozyme Inc. is a biotechnology company based in Gainesville, Florida, focused on developing therapeutic enzymes that degrade oxalate, a substance linked to kidney stones and certain orphan disorders. Established in 2016, the company aims to help patients manage their diets and health by eliminating non-nutrient oxalate from their bodies. One of its key products, Nephure, allows individuals to enjoy various foods without the adverse effects of oxalate accumulation. Through innovative research and scientific expertise, Captozyme seeks to advance healthcare standards by utilizing novel enzymes and live biotherapeutics. As of November 2019, Captozyme operates as a subsidiary of Arranta Bio LLC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.